SARC has established a vast repository of clinical data sets which includes essential clinical trial data acquired over the years from our researchers and collaborators. This data is now available to sarcoma researchers for further study. Funding for the SARC Clinical Data Repository is supported by the sarcoma advocates of The QuadW Foundation.
Available Inventory
The SARC Clinical Data Repository inventory includes data sets from 12 clinical trials, including more than 1,700 patients with various subtypes of sarcoma.
SARC001
Phase II Trial of Imatinib Mesylate in Bone and Soft Tissue Sarcoma
SARC002
Phase III Trial of Gemcitabine v. Gemcitabine Plus Docetaxel in Soft Tissue Sarcoma
SARC003
Phase II Trial of Gemcitabine and Docetaxel in Osteosarcoma, Ewing sarcoma, Chondrosarcoma
SARC004
Phase II Trial of Gemcitabine and Docetaxel in Uterine Leiomyosarcoma
SARC005
Phase II Trial of Adriamycin/ifosfamide and Adriamycin/etoposide in MPNST
SARC006
Phase II Trial of Adriamycin/ifosfamide and Adriamycin/etoposide in MPNST
SARC007
Phase II Trial of Perifosine in Chemo-Insensitive Sarcomas
SARC009
Phase II Trial of Dasatinib in Advanced Sarcomas
SARC016
Phase II Trial of Everolimus With Bevacizumab in MPNST
SARC018 - SPORE 01
Phase II Trial of Mocetinostat and Gemcitabine in Metastatic Leiomyosarcoma
SARC020
Phase II/III Trial of Doxorubicin Hydrochloride or Trabectedin in Metastatic Soft Tissue Sarcoma
SARC021
Phase III Trial of TH-302 with or without Doxorubicin in Soft Tissue Sarcoma
Using the Data Sets
Have an idea for a study that calls for SARC clinical data? We’d like to know about it. Please contact us for details on using our data. We will provide email confirmation once your information has been received.